Latest stories on TLX
Telix Pharmaceuticals: The ITM Deal Could Strengthen The Long-Term Buy Case
Seeking Alpha64 · neutralanalyst
Telix Pharmaceuticals falls -9.9%
The Fly34 · bearishgeneral
Telix Pharmaceuticals falls -10.1%
The Fly34 · bearishgeneral
Telix Pharmaceuticals reports Q3 results
Seeking Alpha74 · bullishearnings
Telix Pharmaceuticals reaffirms FY26 revenue and other income view $1B
The Fly58 · neutralearnings
Telix Pharmaceuticals reports Q2 group revenue $245M vs. $206M last year
The Fly64 · neutralearnings
Telix Reports Third Quarter 2026 Financial Performance
Business Insider52 · neutralearnings
Telix Reports Third Quarter 2026 Financial Performance
GlobeNewswire52 · neutralearnings
Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.
GlobeNewswire63 · neutralproduct/pr
Telix Highlights Pivotal Trials in Prostate, Brain and Renal Cancers and Next Generation Theranostics at EANM
PR Newswire58 · neutralproduct/pr
Profound Medical enters co-education agreement with Telix Pharmaceuticals
The Fly63 · neutralproduct/pr
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
Business Insider63 · neutralproduct/pr
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
GlobeNewswire63 · neutralproduct/pr
Telix to Host Capital Markets Day in Melbourne on November 4, 2026
PR Newswire52 · neutralproduct/pr
Telix Pharmaceuticals: Merger Bodes Well For Long-Term Plan
Seeking Alpha63 · neutralm&a
Why is Telix Pharmaceuticals stock rallying today?
Investing.com Markets50 · neutralgeneral
Telix Pharmaceuticals’ brain cancer imaging drug applied on first U.S. patients
The Fly63 · neutralproduct/pr
First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)
StockTitan73 · bullishproduct/pr
Telix Granted FDA Fast Track Designation for BiPASS Pre-Biopsy Prostate Cancer Imaging
PR Newswire67 · bullishproduct/pr
Telix (TLX) to Buy Germany’s ITM for up to $2.35 Billion to Lock in its Cancer Isotope Supply
Yahoo Top63 · neutralm&a
Telix Pharmaceuticals Limited (TLX) Discusses Strategic Overview and Oncology Pipeline at Research and Development Day - Slideshow
Seeking Alpha55 · neutralproduct/pr
Telix Pharmaceuticals Limited (TLX) M&A Call Transcript
Seeking Alpha50 · neutralm&a
RBC upgrades Telix to Outperform on ITM deal benefits
The Fly61 · neutralanalyst
Telix upgraded to Outperform from Sector Perform at RBC Capital
The Fly61 · neutralanalyst